JPH09502423A - 1‐デアミノ‐8‐d‐アルギニン・バソプレッシンの製造法 - Google Patents
1‐デアミノ‐8‐d‐アルギニン・バソプレッシンの製造法Info
- Publication number
- JPH09502423A JPH09502423A JP7503424A JP50342495A JPH09502423A JP H09502423 A JPH09502423 A JP H09502423A JP 7503424 A JP7503424 A JP 7503424A JP 50342495 A JP50342495 A JP 50342495A JP H09502423 A JPH09502423 A JP H09502423A
- Authority
- JP
- Japan
- Prior art keywords
- phe
- pro
- cys
- asn
- tyr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Cephalosporin Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 1-デアミノ-8-D- アルギニン・バソプレッシンの合成法であって、次の工 程から成る、すなわち、 a) ヘプタペプチド、Mpa(R1)-Tyr-Phe-Gln-Asn-Cys(R2)-Pro-OH (配列特定番 号 1)を調整し、ただし、ここに、R1,R2をスルフヒドリル保護基とする、 b) 工程(a) によるヘプタペプチドを、ジペプチド(R3)-D-Arg(HCl)-Gly-NH2で 縮合し、ただし、ここに、R3 は酸感受性の、アミノ保護基とする、 c) ノナペプチド Mpa(R1)-Tyr-Phe-Gln-Asn-Cys(R2)-Pro-D-Arg(HCl)-Gly-NH2 (配列特定番号 1)を形成し、かつ、 d) 工程(c) によるノナペプチドを、プロトン性溶媒に溶解したヨウ素により 酸化する。 2.請求項 1 の方法であって、ここに、上記スルフヒドリル保護基 R1および R2が同一であってもよく、または、互いに独立に、アセタミドメチル、3級- ブ チル、3級- ブチルスルフェニル、p-メチルベンジル、p-メトキシベンジル、2- (3- ニトロピリジン・スルフェニル)、エチルカルバモイル、トリフェニルメチ ル、および、9-フルオレニルメチルから成るグループから選択したものであって もよい。 3.請求項 2 の方法であって、ここに、上記スルフヒドリル保護基 R1とR2が 共にアセタミドメチルである。 4.請求項 1 の方法であって、ここに、上記アミノ保護基 R3が N-3 級-チロ キシである。 5.請求項 1 の方法であって、ここに、工程(a) の上記へプタペプチドが、 トリペプチドMpa(R1)-Tyr-Phe-X を縮合することから成る製法によって調 製されるが、ただし、ここに、X は、Phe の-COOH 中の OH の位置を、テトラペ プチド R3-Gln-Asn-Cys(R2)-Pro-OHで置換した反応性半量体である。 6.請求項 5 による方法であって、ここに、上記反応性半量体 X は、アルコ キシ、アリロキシ、および、アジドから成るグループから選択したものである。 7.請求項 6 による方法であって、ここに、アルコキシがスクシンイミドキシ である。 8.請求項 6 による方法であって、ここに、アリロキシが p- ニトロフェニロ キシである。 9.請求項 1 による方法であって、ここに、工程(d) のヨウ素による上記酸 化が、pH 5.0 未満で実行される。 10.請求項 9 による方法であって、ここに、ヨウ素による上記酸化が、pH 1.5 -4.3 の間で実行される。 11.請求項 1 による方法であって、ここに、工程(d) による上記酸化ノナペ プチドを含む反応混合液が、酸で平衡させた陽イオン交換樹脂によるイオン交換 クロマトで精製したものである。 12.請求項 1 の方法によって調製された 1- デアミノ-8-D- アルギニン・バソ プレッシン(DDAVP)。 13.請求項 12 の方法で調製された上記 1- デアミノ-8-D- アルギニン・バソプ レッシン(DDAVP) の治療量を投与することから成る、利尿の治療法。 14.下記の構造を含む、請求項 1 の方法によって調製された化合物。 Mpa-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2(配列特定番号 2) 15.適当な放出製剤に溶解させた、請求項 14 による化合物からなる利尿治療法 。 16.請求項 14 による化合物の治療量の投与から成る利尿治療法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/084,847 US5500413A (en) | 1993-06-29 | 1993-06-29 | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
US084,847 | 1993-06-29 | ||
PCT/SE1994/000621 WO1995001373A1 (en) | 1993-06-29 | 1994-06-22 | Process for manufacture of 1-deamino-8-d-arginine vasopressin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09502423A true JPH09502423A (ja) | 1997-03-11 |
JP3453144B2 JP3453144B2 (ja) | 2003-10-06 |
Family
ID=22187597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50342495A Expired - Fee Related JP3453144B2 (ja) | 1993-06-29 | 1994-06-22 | 1‐デアミノ‐8‐d‐アルギニン・バソプレッシンの製造法 |
Country Status (14)
Country | Link |
---|---|
US (1) | US5500413A (ja) |
EP (1) | EP0710247B1 (ja) |
JP (1) | JP3453144B2 (ja) |
KR (1) | KR0163224B1 (ja) |
CN (1) | CN1040648C (ja) |
AT (1) | ATE204296T1 (ja) |
CA (1) | CA2166297C (ja) |
DE (1) | DE69427985T2 (ja) |
DK (1) | DK0710247T3 (ja) |
ES (1) | ES2159562T3 (ja) |
GR (1) | GR3036935T3 (ja) |
HK (1) | HK1000910A1 (ja) |
PT (1) | PT710247E (ja) |
WO (1) | WO1995001373A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016527255A (ja) * | 2013-07-26 | 2016-09-08 | フェリング ベスローテン フェンノートシャップ | バソプレッシン−2受容体アゴニスト |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5674850A (en) * | 1993-12-23 | 1997-10-07 | Ferring Ab | High purity desmopressin produced in large single batches |
DE69424940T2 (de) * | 1993-06-29 | 2000-12-28 | Ferring Bv | Synthese zyklischer peptide |
SE9400918L (sv) * | 1994-03-18 | 1995-09-19 | Anne Fjellstad Paulsen | Stabiliserad komposition för oral administrering av peptider |
US5763398A (en) * | 1996-06-20 | 1998-06-09 | Ferring B.V. | Nasal administration of desmopressin |
US5922680A (en) * | 1996-10-23 | 1999-07-13 | Ferring, B.V. | Stabilized composition for oral administration of peptides |
US8765177B2 (en) * | 1997-09-12 | 2014-07-01 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US7153845B2 (en) * | 1998-08-25 | 2006-12-26 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
KR20040088519A (ko) | 2002-02-22 | 2004-10-16 | 뉴 리버 파마슈티칼스, 인크. | 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법 |
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
ATE334998T1 (de) * | 2003-04-07 | 2006-08-15 | Novetide Ltd | Verfahren zur herstellung cyclischer peptide |
EP1689419A4 (en) * | 2003-11-10 | 2009-01-14 | Reprise Biopharmaceutics Llc | PHARMACEUTICAL COMPOSITIONS WITH LOW DOSES OF DESMOPRESSIN |
DK1530967T3 (da) * | 2003-11-13 | 2006-07-03 | Ferring Bv | Blisterpakning og dertil hörende fast dosisform |
SE0600482L (sv) * | 2006-03-02 | 2006-11-14 | Ferring Int Ct Sa | Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse |
ES2764222T3 (es) * | 2006-09-08 | 2020-06-02 | Wyeth Llc | Lavado con arginina en la purificación de proteínas mediante el uso de cromatografía de afinidad |
US8399410B2 (en) | 2007-08-06 | 2013-03-19 | Allergan, Inc. | Methods and devices for desmopressin drug delivery |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
NO2296686T3 (ja) * | 2008-05-21 | 2014-07-12 | ||
US9539302B2 (en) * | 2009-06-18 | 2017-01-10 | Allergan, Inc. | Safe desmopressin administration |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH495957A (de) * | 1966-09-15 | 1970-09-15 | Ceskoslovenska Akademie Ved | Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids |
US4271068A (en) * | 1968-05-10 | 1981-06-02 | Ciba-Geigy Corporation | Process for the manufacture of cystine-containing peptides |
CH517705A (de) * | 1969-12-16 | 1972-01-15 | Ciba Geigy Ag | Verfahren zur Herstellung von Cystin-haltigen Peptiden |
ZA733419B (en) * | 1972-07-04 | 1974-03-27 | Hoffmann La Roche | Nonapeptides and process for the preparation thereof |
US3929758A (en) * | 1974-09-12 | 1975-12-30 | Armour Pharma | Cyclization of cysteine-containing peptides |
US4033940A (en) * | 1975-11-12 | 1977-07-05 | Armour Pharmaceutical Company | Cyclization of peptides |
US4093610A (en) * | 1977-01-31 | 1978-06-06 | American Home Products Corporation | Process for producing triglycyl-lysine vasopressin and intermediates therefor |
US4216141A (en) * | 1978-07-19 | 1980-08-05 | The Salk Institute For Biological Studies | Method for cyclization of peptides |
DE2923787A1 (de) * | 1979-06-12 | 1980-12-18 | Max Planck Gesellschaft | Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel |
IE56021B1 (en) * | 1982-10-13 | 1991-03-27 | Akzo Nv | Peptides |
SE8306367L (sv) * | 1983-11-18 | 1985-05-19 | Ferring Ab | Antidiuretiskt verkande farmaceutiskt preparat |
US5066716A (en) * | 1988-12-13 | 1991-11-19 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides |
-
1993
- 1993-06-29 US US08/084,847 patent/US5500413A/en not_active Expired - Lifetime
-
1994
- 1994-06-22 ES ES94920616T patent/ES2159562T3/es not_active Expired - Lifetime
- 1994-06-22 PT PT94920616T patent/PT710247E/pt unknown
- 1994-06-22 WO PCT/SE1994/000621 patent/WO1995001373A1/en active IP Right Grant
- 1994-06-22 KR KR1019950706030A patent/KR0163224B1/ko not_active IP Right Cessation
- 1994-06-22 CN CN94192593A patent/CN1040648C/zh not_active Expired - Fee Related
- 1994-06-22 DK DK94920616T patent/DK0710247T3/da active
- 1994-06-22 DE DE69427985T patent/DE69427985T2/de not_active Expired - Lifetime
- 1994-06-22 EP EP94920616A patent/EP0710247B1/en not_active Expired - Lifetime
- 1994-06-22 CA CA002166297A patent/CA2166297C/en not_active Expired - Fee Related
- 1994-06-22 JP JP50342495A patent/JP3453144B2/ja not_active Expired - Fee Related
- 1994-06-22 AT AT94920616T patent/ATE204296T1/de active
-
1997
- 1997-12-22 HK HK97102551A patent/HK1000910A1/xx not_active IP Right Cessation
-
2001
- 2001-10-18 GR GR20010401803T patent/GR3036935T3/el unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016527255A (ja) * | 2013-07-26 | 2016-09-08 | フェリング ベスローテン フェンノートシャップ | バソプレッシン−2受容体アゴニスト |
Also Published As
Publication number | Publication date |
---|---|
CN1040648C (zh) | 1998-11-11 |
WO1995001373A1 (en) | 1995-01-12 |
EP0710247B1 (en) | 2001-08-16 |
PT710247E (pt) | 2001-12-28 |
KR960703411A (ko) | 1996-08-17 |
HK1000910A1 (en) | 2002-03-15 |
DK0710247T3 (da) | 2001-10-01 |
CN1125952A (zh) | 1996-07-03 |
DE69427985D1 (de) | 2001-09-20 |
EP0710247A1 (en) | 1996-05-08 |
ATE204296T1 (de) | 2001-09-15 |
KR0163224B1 (ko) | 1998-11-16 |
DE69427985T2 (de) | 2002-03-28 |
GR3036935T3 (en) | 2002-01-31 |
CA2166297A1 (en) | 1995-01-12 |
ES2159562T3 (es) | 2001-10-16 |
US5500413A (en) | 1996-03-19 |
JP3453144B2 (ja) | 2003-10-06 |
CA2166297C (en) | 2001-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09502423A (ja) | 1‐デアミノ‐8‐d‐アルギニン・バソプレッシンの製造法 | |
US4368192A (en) | Peptides | |
FI72732B (fi) | Foerfarande foer framstaellning av nya, i 8-staellning aminosyraestergrupp innehaollande, angiotensin-ii-antagoniserande oktapeptidestrar. | |
JP4477777B2 (ja) | 新規シクロスポリン | |
EP0132770B1 (de) | Neue Insulin-Derivate, Verfahren zu deren Herstellung und deren Verwendung sowie pharmazeutische Mittel zur Behandlung des Diabetes mellitus | |
US4619916A (en) | Tripeptide compounds containing pyroglutamic acid and tryptophan, process for their production and therapeutic applications | |
US5674850A (en) | High purity desmopressin produced in large single batches | |
WO2021143159A1 (zh) | 一种制备利拉鲁肽的方法 | |
US5204328A (en) | Peptides having atrial natriuretic factor activity | |
US4093610A (en) | Process for producing triglycyl-lysine vasopressin and intermediates therefor | |
HU189757B (en) | Process for producing peptides of psichopharmaceutical activity | |
FI92209C (fi) | Menetelmä terapeuttisesti käyttökelpoisten peptidiyhdisteiden valmistamiseksi | |
EP0122818B1 (fr) | Synthèse du hpGRF (Somatocrinine) en phase liquide et peptides intermédiaires | |
KR870001145B1 (ko) | 펩타이드의 제조방법 | |
HU205771B (en) | Process for producing irreversible peptide ligands for bombesin receptors and process for producing pharmaceutical compositions comprising such peptides as active ingredient | |
KR0171614B1 (ko) | 혈관활성 바소토신 유도체 | |
JPS6033854B2 (ja) | 中枢神経系作用を有するトリペプチド誘導体およびその製法 | |
CN113135989A (zh) | 一种制备利拉鲁肽的方法 | |
DE2327634A1 (de) | Nonapeptide und verfahren zu deren herstellung | |
JPH08333389A (ja) | ヘキサペプチドの製造方法 | |
WO1986003496A1 (fr) | Nouveaux polypeptides hypocalcemiants, leur preparation et les medicaments contenant ces principes actifs | |
IE49262B1 (en) | Psycho-pharmacological peptides,process for their preparation and therapeutical compositions containing them | |
JPH03181499A (ja) | 新規ペプチド | |
JPS6327499A (ja) | α,α’−ジアミノスベリン酸誘導体 | |
JPH06107681A (ja) | ペプチド誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070718 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080718 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080718 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090718 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090718 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100718 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110718 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110718 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120718 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120718 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130718 Year of fee payment: 10 |
|
LAPS | Cancellation because of no payment of annual fees |